Parathyroid hormone-related protein (PTHrP)-dependent modulation of gene expression signatures in cancer cells.
Bone tumor
Breast tumor
Gastrointestinal tumor
Gene signatures
Leukemia/lymphoma
Lung cancer
PTHrP
Prostate tumor
Journal
Vitamins and hormones
ISSN: 0083-6729
Titre abrégé: Vitam Horm
Pays: United States
ID NLM: 0413601
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
11
8
2022
pubmed:
12
8
2022
medline:
16
8
2022
Statut:
ppublish
Résumé
PTHrP is encoded by PTHLH gene which can generate by alternative promoter usage and splicing mechanisms at least three mature peptides of 139, 141 and 173 amino acids with distinct carboxy terminus. PTHrP may undergo proteolytic processing into smaller bioactive forms, comprising an amino terminus peptide, which is the mediator of the "classical" PTH-like effect, as well as midregion and carboxy terminus peptides that act as multifaceted critical regulator of proliferation, differentiation and apoptosis via the reprogramming of gene expression in normal and neoplastic cells. Moreover, a nuclear/nucleolar localization signal sequence is present in the [87-107] domain allowing PTHrP nuclear import and "intracrine" effect additional to the autocrine/paracrine one. Within the large number of data available in the literature on PTHrP bioactivities, the goal of this chapter is to pick up selected studies that report the detection of molecular signatures of cancer cell exposure to PTHrP, either as full-length protein or discrete peptides, demonstrated by individual gene or whole genome expression profiling, briefly recapitulating the biological implications associated with the specific gene activation or silencing.
Identifiants
pubmed: 35953109
pii: S0083-6729(22)00046-2
doi: 10.1016/bs.vh.2022.03.003
pii:
doi:
Substances chimiques
Parathyroid Hormone
0
Parathyroid Hormone-Related Protein
0
Peptides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
179-214Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.